For the Inventor, By the Inventor

Enter assignee name

Chicago, IL, United States of America

Tempus Ai, Inc.

USPTO Granted Patents = 17

EPO Patents = 4

Trademarks = 47

Forward Citations = 3

Loading Chart...

Loading Chart...

68 inventors (with patents filed for the assignee):

Jonathan Ozeran (4 out of 15 patents)

Aly Azeem Khan (4 out of 19 patents)

Eric Lefkofsky (3 out of 12 patents)

4. Richard Blidner (2 out of 4 patents)

5. Stephen Yip (2 out of 13 patents)

6. Ashraf Hafez (2 out of 11 patents)

7. Jason Perera (1 out of 4 patents)

8. Taylor Harding (1 out of 2 patents)

9. Brittany Mineo (1 out of 2 patents)

10. Jenna L Malinauskas (1 out of 2 patents)

11. Brian M Larsen (1 out of 3 patents)

12. Michelle M Stein (1 out of 2 patents)

13. Luka A Karginov (1 out of 2 patents)

14. Ameen Salahudeen (1 out of 5 patents)

15. Madhavi Kannan (1 out of 3 patents)

17 patents: Sort by Forward Citations

1. 12471827 - ECG based future atrial fibrillation predictor systems and methods (2025-11-18),

2. 12462911 - Clinical concept identification, extraction, and prediction system and related methods (2025-11-04),

3. 12451250 - Systems and methods for predicting therapeutic sensitivity (2025-10-21),

4. 12412665 - Methods for evaluating the effect of the start date for cancer treatment with a cancer medication using propensity scoring (2025-09-09),

5. 12365943 - Systems and methods for next generation sequencing uniform probe design (2025-07-22),

6. 12361542 - Systems and methods for deep orthogonal fusion for multimodal prognostic biomarker discovery (2025-07-15),

7. 12271832 - Artificial intelligence engine for directed hypothesis generation and ranking (2025-04-08),

8. 12217429 - 3D radiomic platform for imaging biomarker development (2025-02-04),

9. 12203139 - Systems and methods for detecting multi-molecule biomarkers (2025-01-21),

10. 12190884 - Collaborative artificial intelligence method and system (2025-01-07),

11. 12165753 - Systems and methods for interrogating clinical documents for characteristic data (2024-12-10),

12. 12165236 - Predicting total nucleic acid yield and dissection boundaries for histology slides (2024-12-10),

13. 12129519 - TCR/BCR profiling using enrichment with pools of capture probes (2024-10-29),

14. 12119103 - GANs for latent space visualizations (2024-10-15),

15. 12112839 - Data based cancer research and treatment systems and methods (2024-10-08),

Tempus Ai, Inc. is an innovative technology company specializing in artificial intelligence and machine learning solutions. Founded to harness the power of data analytics, Tempus Ai aims to improve decision-making processes across various sectors by providing cutting-edge AI tools. Their services include data integration, predictive modeling, and advanced analytics that empower businesses to optimize their operations. With a focus on healthcare, finance, and manufacturing industries, Tempus Ai utilizes proprietary algorithms and cloud-based platforms to deliver actionable insights that drive efficiency and growth. The team's expertise and commitment to excellence position Tempus Ai as a leader in the AI landscape, dedicated to transforming industries through technology.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

17 Patents

#213 in Chicago, IL

#935 in Illinois

#18,291 in US

#34,802 in the World

Chicago, IL, United States of America

Tempus Ai, Inc.

Forward Citations = 3

68 inventors:

Jonathan Ozeran (4 out of 15 patents)

Aly Azeem Khan (4 out of 19 patents)

Eric Lefkofsky (3 out of 12 patents)

4. Richard Blidner (2 out of 4 patents)

5. Stephen Yip (2 out of 13 patents)

Please report any incorrect information to support@idiyas.com

Loading…